Pharmafile Logo
Pharmafocus logo
Advanced Search

Xarelto

Showing 15 posts of 74 posts found.

NICE image

NICE decisions made on Bayer, Celgene and Boehringer drugs

March 26, 2015
Sales and Marketing Bayer, Boehringer, Celgene, NHS, Xarelto, imnovid, jardiance

In final guidance NICE has recommended Bayer’s Xarelto and Boehringer’s Jardiance for NHS funding, but not Celgene’s Imnovid. Bayer’s Xarelto …

News
Bayer image

New drugs give Bayer record sales

February 26, 2015
Sales and Marketing Bayer, Eylea, Radium-223 chloride, Stivarga, Xarelto, adempas, aflibercept, dekkers, german, regorafenib, riociguat, xofigo

Bayer has reported strong financial results for 2014 driven primary by sales of new medicines, although controversy surrounding its anti-clotting …

News
Bayer image

Bayer launches major new stroke trial

January 27, 2015
Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke

Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …

News
Xarelto image

NICE recommends Bayer heart attack drug

January 26, 2015
Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban

NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …

News
J&J image

Olysio and Xarelto boost J&J’s Q4

January 21, 2015
Sales and Marketing J&J, JJ, Janssen, NICE, Remicade, Velcade, Xarelto, financials, hep C, olysio, q4, quarter four

Johnson & Johnson earned a 10% increase in worldwide sales of its drugs in the last quarter of 2014 compared …

News
eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

News
Baye image

Xarelto lift for Bayer

March 3, 2014
Manufacturing and Production, Sales and Marketing Bayer, Eylea, Stivarga, Xarelto, blood thinner, xofigo

Bayer Group says sales of its blood thinner Xarelto will be higher than it had predicted, with peak annual sales …

News
pradaxa image

Boehringer in hot water over Pradaxa risks

February 19, 2014
Sales and Marketing Boehringer, Pradaxa, Xarelto, dabigatran, lawsuit

Boehringer Ingelheim attempted to delay and revise the publication of important drug information surrounding its new anticoagulant Pradaxa. This is …

News
Xarelto, bayer, ACS, janssen, fda, asa, blood

Bayer ‘disappointed’ with FDA

February 18, 2014
Sales and Marketing ACS, Bayer, Xarelto, blood, rivaroxaban

Bayer HealthCare has expressed its dismay after the Food and Drug Administration once again rejected further indications for the company’s …

News

‘More than 2,000’ US lawsuits for Boehringer

February 14, 2014
Sales and Marketing Boehringer, Pradaxa, Xarelto, blood thinner, warfarin

Boehringer Ingelheim is facing more than 2,000 lawsuits in the US over allegations that its stroke prevention pill Pradaxa has …

News
Xarelto image

FDA has Xarelto concerns

July 2, 2013
Sales and Marketing Bayer, Boehringer, FDA, Pradaxa, Xarelto

The FDA is unsure about an application to further extend the licence for Janssen and Bayer HealthCare’s blood thinner Xarelto …

News
Xarelto image

Xarelto gets ACS indication

May 29, 2013
Sales and Marketing ACS, Bayer, Xarelto

Bayer HealthCare’s bloodthinner Xarelto has expanded its reach in Europe with approval for secondary prevention after an acute coronary syndrome …

News
Xarelto image

German regulator assesses more drugs

April 22, 2013
Sales and Marketing AMNOG, Bayer, Germany, Pradaxa, Xarelto

A new raft of drugs which will be subject to potentially stringent cost/benefit analysis in Germany has been announced. The …

News
Xarelto image

Xarelto gets EU nod

March 25, 2013
Sales and Marketing Bayer, Xarelto

Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …

News
Xarelto image

New AF possibility for Xarelto

March 11, 2013
Sales and Marketing Bayer, FDA, Xarelto

Bayer HealthCare is to launch a new trial of its oral blood thinner Xarelto just days after the FDA knocked …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025